Biomarkers of Acute Kidney Injury (NGAL, Cystatin C)

Rationale For Diagnostic Shift

Traditional reliance on serum creatinine has severe physiological limitations in pediatric intensive care.
Creatinine exhibits a delayed rise of 48 to 72 hours post-injury, depends heavily on skeletal muscle mass, and is artificially lowered by aggressive fluid resuscitation.
Newer biomarkers address this creatinine blind spot by detecting acute kidney injury (AKI) in real-time before functional decline occurs.

Cystatin C is a 13-kDa non-glycosylated basic protein produced continuously by all nucleated cells.
It is freely filtered by the glomerulus and completely catabolized by proximal tubular epithelial cells without urinary excretion.
Serum levels provide a highly precise and direct reflection of the glomerular filtration rate (GFR).
Levels rise significantly earlier than creatinine, typically within 12 to 24 hours of an acute GFR decline.
Values are entirely independent of age, gender, and skeletal muscle mass in children older than 12 to 18 months.
The CKiD U25 equation utilizing Cystatin C now replaces traditional creatinine-based equations for accurate eGFR calculation.
Values can be confounded and artificially elevated by severe hyperthyroidism and high-dose systemic corticosteroids.

Neutrophil gelatinase-associated lipocalin (NGAL) is a 25-kDa protein massively upregulated in the thick ascending limb and collecting ducts following ischemic or nephrotoxic insults.
Universally recognized as the troponin of the kidney due to its ability to detect structural damage.
Urinary and plasma NGAL levels surge 10-fold to 100-fold within 2 to 4 hours of injury, preceding the rise in serum creatinine by 2 to 3 full days.
Urinary NGAL specifically reflects direct tubular damage, whereas plasma NGAL can be falsely elevated by systemic sepsis and urinary tract infections.
Clinically utilized post-cardiopulmonary bypass to predict severe AKI within just 2 hours of surgery.
Acts as a critical early warning surveillance tool in nephrotoxic antimicrobial stewardship programs to prompt early drug de-escalation.

Tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) are novel multiplex markers.
These mathematically combined markers indicate that renal tubular cells have entered G1 cell-cycle arrest to avoid replicating damaged DNA.
They are highly specific to renal injury and are not artificially elevated by systemic sepsis.

ADQI AKI Stage	Functional Marker (Creatinine/Cystatin C)	Damage Marker (NGAL)	Clinical Implication
Subclinical AKI	Normal	Elevated	Active damage without functional loss yet.
Stage 1A	Elevated	Normal	No active structural damage, likely simple prerenal dehydration requiring fluids.
Stage 1B	Elevated	Elevated	Established tubular necrosis requiring immediate cessation of nephrotoxins and strict fluid restriction.